Skip to main content
Premium Trial:

Request an Annual Quote

Leiden University Medical Center To Use FlexGen's FlexArrayer

NEW YORK (GenomeWeb News) - Leiden University Medical Center said yesterday that it has acquired a FlexArrayer from FlexGen for in-house synthesis of oligonucleotide microarrays.
 
FlexGen is a LUMC spinoff company.
 
Johan den Dunnen, head of the Leiden Genome Technology Center, said in a statement that the center will use the FlexArrayer for “well established types of genetic analyses but [we] also intend to work on the development of new applications.”
 
Specifically, den Dunnen said, LGTC is “keen to implement” the system for array-based hybridization capture to sequence specific DNA regions.
 
Financial terms of the agreement were not provided.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.